Assessing the performance of a serological point-of-care test in measuring detectable antibodies against SARS-CoV-2.

Assessing the performance of a serological point-of-care test in measuring detectable antibodies against SARS-CoV-2.

This study investigated the performance of a rapid point-of-care antibody test, the BioMedomics COVID-19 IgM/IgG Rapid Test, in comparison with a high-quality, validated, laboratory-based platform, the Roche Elecsys Anti-SARS-CoV-2 assay. Serological testing was conducted on 709 individuals. Concord...

Full description

Bibliographic Details
Main Authors: Peter V Coyle, Reham Awni El Kahlout, Soha R Dargham, Hiam Chemaitelly, Mohamed Ali Ben Hadj Kacem, Naema Hassan Abdulla Al-Mawlawi, Imtiaz Gilliani, Nourah Younes, Zaina Al Kanaani, Abdullatif Al Khal, Einas Al Kuwari, Andrew Jeremijenko, Anvar Hassan Kaleeckal, Ali Nizar Latif, Riyazuddin Mohammad Shaik, Hanan F Abdul Rahim, Gheyath K Nasrallah, Hadi M Yassine, Mohamed G Al Kuwari, Hamad Eid Al Romaihi, Patrick Tang, Roberto Bertollini, Mohamed H Al-Thani, Laith J Abu-Raddad
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0262897

Internet

https://doi.org/10.1371/journal.pone.0262897

Similar Items